Español
Questions About Cancer? 1-800-4-CANCER
  • Email

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-17 of 17 for your search:
Drug:  rubitecan
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase III
Type: Treatment
Status: Closed
Age: Over 18
Sponsor: Pharmaceutical / Industry
Protocol IDs: SUPERGEN-RFS2000-02, NCT00005869

2.

Phase: Phase III
Type: Treatment
Status: Closed
Age: Over 18
Sponsor: Pharmaceutical / Industry
Protocol IDs: SUPERGEN-RFS2000-09, RPCI-DS-99-11, NCT00005870

3.

Phase: Phase III
Type: Treatment
Status: Closed
Age: Over 18
Sponsor: Pharmaceutical / Industry
Protocol IDs: SUPERGEN-RFS2000-06, PCI-99-001, NCT00005871

4.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: SFFCR-IND-45-952, NCI-V96-0998

5.

Phase: Phase II
Type: Treatment
Status: Completed
Age: Not specified
Sponsor: NCI, Other
Protocol IDs: CDR0000067827, CLB-99901, GUMC-00192, CALGB-99901, NCT00005820

6.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: EORTC-16996G, NCT00005826

7.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: SUPERGEN-RFS2000-16, DFCI-99184, NCT00005872

8.

Phase: Phase II
Type: Treatment
Status: Completed
Age: Not specified
Sponsor: Pharmaceutical / Industry
Protocol IDs: SUPERGEN-RFS2000-17, IUMC-9906-11, NCT00005873

9.

Phase: Phase II
Type: Treatment
Status: Completed
Age: Not specified
Sponsor: Pharmaceutical / Industry
Protocol IDs: SUPERGEN-RFS2000-24, MDA-DM-99109, NCT00005874

10.

Phase: Phase II
Type: Treatment
Status: Completed
Age: Over 16
Sponsor: Pharmaceutical / Industry
Protocol IDs: SUPERGEN-RFS2000-10, MDA-DM-98237, NCT00005875

11.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: SUPERGEN-RFS2000-30, MDA-DM-99231, NCT00005876

12.

Phase: Phase II
Type: Treatment
Status: Closed
Age: Not specified
Sponsor: Pharmaceutical / Industry
Protocol IDs: SUPERGEN-RFS2000-18, PCI-99-037, NCT00005877

13.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: EORTC-16996U, NCT00006026

14.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: EORTC-16996SL, NCT00006082

15.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: EORTC-16996O, NCT00006230

16.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: MCC-12177, NCI-G00-1821, NCT00006047

17.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: RFS 2000-40, SGI-RUB-040, RFS 2000-040, NCT00113113
New Search